TechAstrazeneca's New COVID Antibody Drug Promises Instant Coronavirus Immunity Enters Phase 3 Trials Scientists are studying the possibility of providing instant long-term immunity to patients who are at higher risk using the new COVID antibody drug developed by Astrazeneca.by CJ Robles
TechContact Tracing Tokens in Schools, Aims to Distribute 5 Million Tokens by February 2021by Sieeka Khan
HealthExperts Claim UK's Mutant Coronavirus Strain May Already Be in the US, Are Children Really More Vulnerable?by Giuliano J. de Leon
TechNew Study Claims Using Smartphone Apps Can Lower Cancer Risks and Other Diseasesby Giuliano J. de Leon
HealthFBI Warns of Scams Seeking Downpayments for Alleged COVID Vaccine Through Ads, Emails, and Moreby Urian B.
HealthPost COVID-19 Vaccine: What Activities Can You Do and When Can Things Go Back to Normal?by Nhx T.
HealthCDC's New COVID-19 Guidelines For Allergic People; Here Are the Recommendations You Needby Giuliano J. de Leon
HealthUK New Strain of COVID-19 70% More Contagious, Already Had Nearly Two Dozen Mutationsby CJ Robles